WallStreetZen

NYSE: BMY
Bristol Myers Squibb Co Stock Forecast, Predictions & Price Target

Analyst price target for BMY

Based on 11 analysts offering 12 month price targets for Bristol Myers Squibb Co.
Min Forecast
$65.00+1.28%
Avg Forecast
$72.82+13.46%
Max Forecast
$80.00+24.65%

Should I buy or sell BMY stock?

Buy
Strong Buy
8 analysts 53.33%
Buy
1 analysts 6.67%
Hold
6 analysts 40%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Forecast return on equity

Is BMY forecast to generate an efficient return?
Company
37.39%
Industry
75.15%
Market
62.3%
BMY's Return on Equity is forecast to be high in 4 years (37.39%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is BMY forecast to generate an efficient return on assets?
Company
14.94%
Industry
16.93%
Market
19.84%
BMY is forecast to generate lower Return on Assets (14.94%) than the US Drug Manufacturers - General industry average (16.93%)
Forecast

BMY earnings per share forecast

What is BMY's earnings per share in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
$7.32-2,714.29%
Avg 2 year Forecast
$7.80-2,886.32%
Avg 3 year Forecast
$8.13-3,003.57%

BMY revenue forecast

What is BMY's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$45.4B+15.25%
Avg 2 year Forecast
$47.1B+19.44%
Avg 3 year Forecast
$49.0B+24.4%
BMY's revenue is forecast to grow at a rate of 7.49% per year, which is not exceptional
Forecast

BMY revenue growth forecast

How is BMY forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
7.49%
Industry
6.43%
Market
14.47%
BMY's revenues are forecast to grow faster (7.49% per year) than the US Drug Manufacturers - General industry average (6.43%)
Forecast
BMY's revenues are forecast to grow slower (7.49% per year) than the US market average (14.47%)
Forecast

Bristol Myers Squibb Stock Forecast FAQ

Is Bristol Myers Squibb Stock a good buy in 2020, according to Wall Street analysts?

The consensus among 15 Wall Street analysts covering (NYSE: BMY) stock is to Buy BMY stock.

Out of 15 analysts, 8 (53.33%) are recommending BMY as a Strong Buy, 1 (6.67%) are recommending BMY as a Buy, 6 (40%) are recommending BMY as a Hold, 0 (0%) are recommending BMY as a Sell, and 0 (0%) are recommending BMY as a Strong Sell.

What is BMY's Price Target?

According to 11 Wall Street analysts that have issued a 1 year BMY price target, the average BMY price target is $72.82, with the highest BMY stock price forecast at $80.00 and the lowest BMY stock price forecast at $65.00.

On average, Wall Street analysts predict that Bristol Myers Squibb's share price could reach $72.82 by Jan 14, 2022. The average Bristol Myers Squibb stock price prediction forecasts a potential upside of 13.46% from the current BMY share price of $64.18.

What is BMY's earnings growth forecast for 2021-2023?

(NYSE: BMY) Bristol Myers Squibb's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 25.09%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 20.63%.

Bristol Myers Squibb's earnings in 2020 is -$44,000,000.On average, 8 Wall Street analysts forecast BMY's earnings for 2021 to be $16,498,801,528, with the lowest BMY earnings forecast at $15,642,306,367, and the highest BMY earnings forecast at $16,814,352,377. On average, 6 Wall Street analysts forecast BMY's earnings for 2022 to be $17,584,521,842, with the lowest BMY earnings forecast at $16,881,970,416, and the highest BMY earnings forecast at $18,031,477,080.

In 2023, BMY is forecast to generate $18,324,488,583 in earnings, with the lowest earnings forecast at $17,580,690,153 and the highest earnings forecast at $19,361,298,515.

What is BMY's revenue growth forecast for 2021-2023?

(NYSE: BMY) Bristol Myers Squibb's forecast annual revenue growth rate of 7.49% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.43%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.47%.

Bristol Myers Squibb's revenue in 2020 is $39,395,000,000.On average, 5 Wall Street analysts forecast BMY's revenue for 2021 to be $102,330,620,399,348, with the lowest BMY revenue forecast at $101,352,002,551,655, and the highest BMY revenue forecast at $102,931,334,550,399. On average, 5 Wall Street analysts forecast BMY's revenue for 2022 to be $106,055,008,466,614, with the lowest BMY revenue forecast at $104,118,188,911,151, and the highest BMY revenue forecast at $109,041,075,165,494.

In 2023, BMY is forecast to generate $110,455,944,315,726 in revenue, with the lowest revenue forecast at $108,919,137,301,740 and the highest revenue forecast at $113,507,021,251,283.

What is BMY's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: BMY) Bristol Myers Squibb's current Earnings Per Share (EPS) is -$0.28. On average, analysts forecast that BMY's EPS will be $7.32 for 2021, with the lowest EPS forecast at $6.94, and the highest EPS forecast at $7.46. On average, analysts forecast that BMY's EPS will be $7.80 for 2022, with the lowest EPS forecast at $7.49, and the highest EPS forecast at $8.00. In 2023, BMY's EPS is forecast to hit $8.13 (min: $7.80, max: $8.59).

What is BMY's forecast return on equity (ROE) for 2021-2024?

(NYSE: BMY) forecast ROE is 37.39%, which is considered strong.

What is BMY's forecast return on assets (ROA) for 2021-2024?

(NYSE: BMY) forecast ROA is 14.94%, which is lower than the forecast US Drug Manufacturers - General industry average of 16.93%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics